Stakes Are High For Companies Negotiating CIAs

Law360, New York (October 2, 2012, 1:27 PM EDT) -- Large pharmaceutical companies continue to resolve health care fraud investigations with epic settlements. As the dollars climb, the corporate integrity agreements (CIAs) typically filed in connection with these settlements are becoming increasingly onerous and stringent enforcement tools. GlaxoSmithKline PLC’s July 2012 $3 billion settlement with the United States Attorney’s Office for the District of Massachusetts has garnered attention not only due to its size, but also because of the unprecedented compliance obligations set forth in the corresponding CIA.

The $3 billion fine — the largest health...
To view the full article, register now.